Works about ESCITALOPRAM

Results: 444

Escitalopram co-prescription in anastrozole-treated breast cancer patients.

Published in:

Northern Clinics of Istanbul, 2022, v. 9, n. 3, p. 248, doi. 10.14744/nci.2022.48264

By:

Ozyurt, Hazan;
Ozden, Sevgi;
Gemici, Cengiz;
Kucukibrahimoglu, Esra;
Odabas, Hatice;
Nesetoglu, Neset;
Unal, Durisehvar;
Uler, Pinar;
Yaprak, Gokhan;
Tepetam, Huseyin;
Gumus, Mahmut;
Goren, Mehmet Zafer

Publication type:

Article

Evaluation of escitalopram induced reproductive toxicity in male Swiss albino mice.

Published in:

Journal of Research in Pharmacy, 2023, v. 27, n. 1, p. 364, doi. 10.29228/jrp.318

By:

AGRAWAL, Karuna;
SHAHANI, Lata;
BHATNAGAR, Pradeep

Publication type:

Article

The psychoactive drug Escitalopram affects swimming behaviour and increases boldness in zebrafish (<italic>Danio rerio</italic>).

Published in:

Ecotoxicology, 2018, v. 27, n. 4, p. 485, doi. 10.1007/s10646-018-1920-x

By:

Nielsen, Sebastian V.;
Kellner, Martin;
Henriksen, Per G.;
Olsén, Håkan;
Hansen, Steen H.;
Baatrup, Erik

Publication type:

Article

Stereo-Psychopharmacology: The Case of Citalopram and Escitalopram.

Published in:

Clinical Pharmacology in Drug Development, 2016, v. 5, n. 5, p. 331, doi. 10.1002/cpdd.293

By:

Ng, Isaac;
Greenblatt, H. Karl;
Greenblatt, David J.

Publication type:

Article

Electroacupuncture versus Escitalopram for mild to moderate Post-Stroke Depression: A randomized non-inferiority trial.

Published in:

Frontiers in Psychiatry, 2024, p. 1, doi. 10.3389/fpsyt.2024.1332107

By:

Feixiang Ma;
Guiping Cao;
Lu Lu;
Yingling Zhu;
Wanlang Li;
Li Chen

Publication type:

Article

Efficacy and safety of repeated transcranial magnetic stimulation combined with escitalopram in the treatment of major depressive disorder: a meta-analysis.

Published in:

Frontiers in Psychiatry, 2024, p. 1, doi. 10.3389/fpsyt.2023.1275839

By:

Zhang Liu;
Sijia Yu;
Youfan Hu;
Ding Wang;
Shuyu Wang;
Zhaohui Tang;
Weihong Li

Publication type:

Article

Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00764

By:

Chakroborty, Shreaya;
Geisbush, Thomas R.;
Dale, Elena;
Pehrson, Alan L.;
Sánchez, Connie;
West, Anthony R.

Publication type:

Article

Can Online Consumers Contribute to Drug Knowledge? A Mixed-Methods Comparison of Consumer-Generated and Professionally Controlled Psychotropic Medication Information on the Internet.

Published in:

Journal of Medical Internet Research, 2011, v. 13, n. 3, p. 9, doi. 10.2196/jmir.1716

By:

Hughes, Shannon;
Cohen, David

Publication type:

Article

Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram.

Published in:

Clinical & Experimental Dermatology, 2016, v. 41, n. 5, p. 526, doi. 10.1111/ced.12851

By:

Eskeland, S.;
Tanum, L.;
Halvorsen, J. A.

Publication type:

Article

Silymarin attenuates escitalopram (cipralex) induced pancreatic injury in adult male albino rats: a biochemical, histological, and immunohistochemical approach.

Published in:

Anatomy & Cell Biology, 2023, v. 56, n. 1, p. 122, doi. 10.5115/acb.22.204

By:

Salama, Rasha Mamdouh;
Tayel, Sara Gamal

Publication type:

Article

Efficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial.

Published in:

Perspectives in Clinical Research, 2016, v. 7, n. 1, p. 45, doi. 10.4103/2229-3485.173771

By:

Gupta, Brij Mohan;
Zargar, Samir H.;
Arora, Manu;
Tandon, Vishal R.

Publication type:

Article

Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression – a secondary outcome analysis from the randomized AGENDA trial.

Published in:

Nordic Journal of Psychiatry, 2016, v. 70, n. 4, p. 297, doi. 10.3109/08039488.2015.1109138

By:

Knorr, Ulla;
Koefoed, Pernille;
Gluud, Christian;
Wetterslev, Jørn;
Winkel, Per;
Gether, Ulrik;
Vinberg, Maj;
Kessing, Lars V.

Publication type:

Article

Effects of Selective Seratonine Re-Uptake Inhibitors on Meniere's Disease.

Published in:

Journal of International Advanced Otology, 2017, v. 13, n. 2, p. 276, doi. 10.5152/iao.2017.3042

By:

Kıroğlu, Olcay;
Sürmelioğlu, Özgür;
Kıroğlu, Mete

Publication type:

Article

Potential Anti-Inflammatory Effect of Escitalopram in Iodoacetamide-Induced Colitis in Depressed Ovariectomized Rats: Role of α7-nAChR.

Published in:

Inflammation, 2019, v. 42, n. 6, p. 2056, doi. 10.1007/s10753-019-01068-0

By:

Abdo, Salah A.;
Wadie, Walaa;
Abdelsalam, Rania M.;
Khattab, Mahmoud M.

Publication type:

Article

SSRIs for Hot Flashes: A Systematic Review and Meta-Analysis of Randomized Trials.

Published in:

JGIM: Journal of General Internal Medicine, 2014, v. 29, n. 1, p. 204, doi. 10.1007/s11606-013-2535-9

By:

Shams, Taghreed;
Firwana, Belal;
Habib, Farida;
Alshahrani, Abeer;
AlNouh, Badria;
Murad, Mohammad;
Ferwana, Mazen

Publication type:

Article

Low SSRI dosing in clinical practice—a register‐based longitudinal study.

Published in:

Acta Psychiatrica Scandinavica, 2021, v. 143, n. 5, p. 434, doi. 10.1111/acps.13275

By:

Lisinski, Alexander;
Hieronymus, Fredrik;
Eriksson, Elias;
Wallerstedt, Susanna M.

Publication type:

Article

Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: Is one better than the other?

Published in:

Acta Psychiatrica Scandinavica, 2013, v. 127, n. 4, p. 330, doi. 10.1111/acps.12068

By:

Uher, R.;
Mors, O.;
McGuffin, P.

Publication type:

Article

Escitalopram versus nortriptyline: How to let the clinical GENDEP data tell us what they contained.

Published in:

Acta Psychiatrica Scandinavica, 2013, v. 127, n. 4, p. 328, doi. 10.1111/acps.12067

By:

P., Bech;
P., Allerup;
E. R., Larsen;
C., Csillag;
R. W., Licht

Publication type:

Article

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.

Published in:

2019

By:

Zhou, Jingjing;
Wang, Weiwei;
Yang, Jian;
Zhu, Xuequan;
Feng, Lei;
Xiao, Le;
Wang, Gang

Publication type:

journal article

Prevention of depression in patients with acute coronary syndrome ( DECARD) randomized trial: effects on and by self-reported health.

Published in:

Early Intervention in Psychiatry, 2015, v. 9, n. 5, p. 370, doi. 10.1111/eip.12119

By:

Hjorthøj, Carsten Rygaard;
Hansen, Baiba Hedegaard;
Hanash, Jamal Abed;
Rasmussen, Alice;
Birket‐Smith, Morten

Publication type:

Article

Revue systématique de méta-analyses évaluant l'efficacité des moyens thérapeutiques dans les troubles somatoformes et apparentés.

Published in:

Médecine, 2022, v. 18, n. 7, p. 330, doi. 10.1684/med.2022.799

By:

Sevin, Carla;
Sun, Sophie;
Vicens, Maud;
Ollivier, Pauline;
Jaafari, Nemat;
Boussageon, Rémy

Publication type:

Article

Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Patients with Chronic Depression: Results from a Naturalistic Long-Term Follow-Up.

Published in:

2017

By:

Bausch, Paul;
Fangmeier, Thomas;
Schramm, Elisabeth;
Zobel, Ingo;
Drost, Sarah;
Schnell, Knut;
Walter, Henrik;
Berger, Mathias;
Schoepf, Dieter;
Normann, Claus

Publication type:

journal article

Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major Depression.

Published in:

Psychotherapy & Psychosomatics, 2015, v. 84, n. 4, p. 227, doi. 10.1159/000381957

By:

Schramm, Elisabeth;
Zobel, Ingo;
Schoepf, Dieter;
Fangmeier, Thomas;
Schnell, Knut;
Walter, Henrik;
Drost, Sarah;
Schmidt, Paul;
Brakemeier, Eva-Lotta;
Berger, Mathias;
Normann, Claus

Publication type:

Article

A Very Sensitive Bioanalytical Method for the Estimation of Escitalopram in Rat Plasma Using Liquid Chromatography with Tandem Mass Spectrometry-Application to Animal Pharmacokinetic Stud.

Published in:

Indian Journal of Pharmaceutical Sciences, 2022, v. 84, n. 2, p. 380, doi. 10.36468/pharmaceutical-sciences.931

By:

RAI, AMITA;
SHETTY, RAGHAVENDRA;
PRABHU, HARISH;
THEERTHAHALLI, ARUNA;
KUMAR, N.;
KRISHNADAS, N.;
KHAN, A. H.

Publication type:

Article

An Assessment of Crosstalk between Serotonin and Dopamine Systems after Escitalopram Treatment Using LC-MS Technique with Ion-trap Analyser.

Published in:

Indian Journal of Pharmaceutical Sciences, 2020, v. 82, n. 4, p. 612, doi. 10.36468/pharmaceutical-sciences.687

By:

NALLELLA, PRATHYUSHA S.;
KUMAR, NITESH;
MOORKOTH, S.

Publication type:

Article

Second-generation anti-depressants and risk of new-onset seizures in the elderly.

Published in:

Clinical Toxicology (15563650), 2018, v. 56, n. 12, p. 1179, doi. 10.1080/15563650.2018.1483025

By:

Finkelstein, Yaron;
Macdonald, Erin M.;
Li, Ping;
Mamdani, Muhammad M.;
Gomes, Tara;
Juurlink, David N.

Publication type:

Article

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 826, doi. 10.1002/cpt.3537

By:

Jang, Yoo Jin;
Kim, Doh Kwan;
Lim, Shinn‐Won;
Hong, Eunjin

Publication type:

Article

Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 860, doi. 10.1002/cpt.3184

By:

Poweleit, Ethan A.;
Vaughn, Samuel E.;
Desta, Zeruesenay;
Dexheimer, Judith W.;
Strawn, Jeffrey R.;
Ramsey, Laura B.

Publication type:

Article

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects.

Published in:

Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 886, doi. 10.1002/cpt.2487

By:

Becker, Anna M.;
Holze, Friederike;
Grandinetti, Tanja;
Klaiber, Aaron;
Toedtli, Vanja E.;
Kolaczynska, Karolina E.;
Duthaler, Urs;
Varghese, Nimmy;
Eckert, Anne;
Grünblatt, Edna;
Liechti, Matthias E.

Publication type:

Article

A Novel CYP2C‐Haplotype Associated With Ultrarapid Metabolism of Escitalopram.

Published in:

Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 786, doi. 10.1002/cpt.2233

By:

Bråten, Line Skute;
Haslemo, Tore;
Jukic, Marin M.;
Ivanov, Maxim;
Ingelman‐Sundberg, Magnus;
Molden, Espen;
Kringen, Marianne Kristiansen

Publication type:

Article

Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 5, p. 447, doi. 10.1002/hup.2330

By:

Bui, Eric;
Orr, Scott P.;
Jacoby, Ryan J.;
Keshaviah, Aparna;
LeBlanc, Nicole J.;
Milad, Mohammed R.;
Pollack, Mark H.;
Simon, Naomi M.

Publication type:

Article

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 5, p. 516, doi. 10.1002/hup.2340

By:

Ng, Chee;
Sarris, Jerome;
Singh, Ajeet;
Bousman, Chad;
Byron, Keith;
Peh, Lai Huat;
Smith, Deidre Joy;
Tan, Chay Hoon;
Schweitzer, Isaac

Publication type:

Article

The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 6, p. 534, doi. 10.1002/hup.2265

By:

Bellantuono, Cesario;
Bozzi, Francesca;
Orsolini, Laura;
Catena-Dell'Osso, Mario

Publication type:

Article

Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.

Published in:

Experimental Brain Research, 2014, v. 232, n. 3, p. 935, doi. 10.1007/s00221-013-3806-8

By:

Kostyalik, Diána;
Kátai, Zita;
Vas, Szilvia;
Pap, Dorottya;
Petschner, Péter;
Molnár, Eszter;
Gyertyán, István;
Kalmár, Lajos;
Tóthfalusi, László;
Bagdy, Gyorgy

Publication type:

Article

Metabolomic signatures associated with depression and predictors of antidepressant response in humans: A CAN-BIND-1 report.

Published in:

Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02421-6

By:

Caspani, Giorgia;
Turecki, Gustavo;
Lam, Raymond W.;
Milev, Roumen V.;
Frey, Benicio N.;
MacQueen, Glenda M.;
Müller, Daniel J.;
Rotzinger, Susan;
Kennedy, Sidney H.;
Foster, Jane A.;
Swann, Jonathan R.

Publication type:

Article

Escitalopram in patients with psoriasis.

Published in:

European Psychiatry, 2021, v. 64, p. S242, doi. 10.1192/j.eurpsy.2021.650

By:

Artemieva, M.;
Danilin, I.;
Ziewozinska, Z.;
Suleimanov, R.;
Lazukova, A.

Publication type:

Article

Efficacy of escitalopram in combination with vitamin D3 supplementation in the depressed perimenopausal women.

Published in:

European Psychiatry, 2020, v. 63, p. S109

By:

Fedotova, J.;
Bereza, Z.;
Dudnichenko, T.

Publication type:

Article

Escitalopram orally-disintegrating tablets (ODT) in major depression treatment.

Published in:

European Psychiatry, 2016, v. 33, p. S177, doi. 10.1016/j.eurpsy.2016.01.301

By:

Polikowska, M.;
Łoza, B.

Publication type:

Article

Efficacy and safety of generic escitalopram (Lexacure) in patients with major depressive disorder: A 6-week, multi-center, randomized, rater-blinded, escitalopram-comparative, non-inferiority study.

Published in:

European Psychiatry, 2016, v. 33, p. S269, doi. 10.1016/j.eurpsy.2016.01.560

By:

Jeong, J.H.;
Bahk, W.M.;
Woo, Y.S.;
Lee, K.U.;
Kim, M.D.;
Kim, W.;
Yang, J.C.;
Lee, K.H.;
Lee, S.Y.

Publication type:

Article

The Impact of Guidance On Citalopram's Effects On the QT Period On the Practice of Clinicians.

Published in:

European Psychiatry, 2015, v. 30, p. 630, doi. 10.1016/S0924-9338(15)30500-9

By:

Agius, M.;
Austin, J.;
Yi, K.;
Zaman, R.

Publication type:

Article

Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: An open trial.

Published in:

European Psychiatry, 2015, v. 30, n. 1, p. 65, doi. 10.1016/j.eurpsy.2014.08.007

By:

Scantamburlo, G.;
Hansenne, M.;
Geenen, V.;
Legros, J.J.;
Ansseau, M.

Publication type:

Article

Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study.

Published in:

Biomedicines, 2023, v. 11, n. 12, p. 3245, doi. 10.3390/biomedicines11123245

By:

Mahajna, Mahmood;
Abu Fanne, Rami;
Berkovitch, Matitiahu;
Tannous, Elias;
Vinker, Shlomo;
Green, Ilan;
Matok, Ilan

Publication type:

Article

The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression.

Published in:

Biomedicines, 2022, v. 10, n. 2, p. 412, doi. 10.3390/biomedicines10020412

By:

Cantero-García, Noelia;
Flores-Burgess, Antonio;
Ladrón de Guevara-Miranda, David;
Serrano, Antonia;
García-Durán, Laura;
Puigcerver, Araceli;
Fuxe, Kjell;
Narváez, José Ángel;
Santín, Luis Javier;
Díaz-Cabiale, Zaida;
Millón, Carmelo

Publication type:

Article

Serotonin syndrome caused by a CYP2C19-mediated interaction between low-dose escitalopram and clopidogrel: a case report.

Published in:

Frontiers in Psychiatry, 2023, p. 1, doi. 10.3389/fpsyt.2023.1257984

By:

Jianhong Wu;
Jiao Yu;
Kankan Qu;
Jiajun Yin;
Chunming Zhu;
Xiaowei Liu

Publication type:

Article

Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis.

Published in:

Frontiers in Psychiatry, 2023, p. 1, doi. 10.3389/fpsyt.2023.1248397

By:

Kenichi Kimura;
Hisashi Narita;
Hissei Imai;
Hisashi Akiyama;
Shuhei Ishikawa;
Ryo Sawagashira;
Tomoyuki Isoyama;
Mariko Nohara;
Michiyo Kawamura;
Yukari Kono;
Takuya Saito;
Ichiro Kusumi

Publication type:

Article

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine.

Published in:

Frontiers in Psychiatry, 2023, p. 1, doi. 10.3389/fpsyt.2023.1188175

By:

Zhe Li;
Ting-Ting Wu;
Yi-Ting Xiong;
Xin-Yang Zhang;
Yan-Ping Bao;
Li-Bo Guo;
Bao-Jie Han;
Su-Xia Li;
Yu-Feng Wang;
Lin Lu;
Xue-Qin Wang

Publication type:

Article

Editorial: Women in psychiatry 2022: Psychopharmacology.

Published in:

Frontiers in Psychiatry, 2023, v. 13, p. 1, doi. 10.3389/fpsyt.2022.1126021

By:

Camarini, Rosana;
Stadlin, Alfreda;
Jan, Reem Kais

Publication type:

Article

Behavioral, cortical and autonomic effects of single-dose escitalopram on the induction and regulation of fear and disgust: Comparison with single-session psychological emotion regulation with reappraisal.

Published in:

Frontiers in Psychiatry, 2023, v. 13, p. 1, doi. 10.3389/fpsyt.2022.988893

By:

Greenfield, Myrto Sklivanioti;
Yanlu Wang;
Msghina, Mussie

Publication type:

Article

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy.

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.972141

By:

Eichentopf, Luzie;
Hiemke, Christoph;
Conca, Andreas;
Engelmann, Jan;
Gerlach, Manfred;
Havemann-Reinecke, Ursula;
Hefner, Gudrun;
Florio, Vincenzo;
Kuzin, Maxim;
Lieb, Klaus;
Reis, Margareta;
Riemer, Thomas G.;
Serretti, Alessandro;
Schoretsanitis, Georgios;
Zernig, Gerald;
Gründer, Gerhard;
Hart, Xenia M.

Publication type:

Article

Effect of escitalopram on cardiomyopathy-induced anxiety in mice.

Published in:

Human & Experimental Toxicology, 2013, v. 32, n. 6, p. 632, doi. 10.1177/0960327112462728

By:

Anwar, M. J.;
Pillai, K.K.;
Samad, A.;
Vohora, D.

Publication type:

Article